Unlocking the Formulation Potential of Cyclodextrins and Their Derivatives—Volume II

Dear Colleagues,

Cyclodextrins are water-soluble, biocompatible macrocyclic oligosaccharides made of α-d-glucopyranose units joined by α(1–4) linkages. These versatile molecules were discovered over a century ago. From then to now, cyclodextrins and their derivatives have served as drug delivery systems with several applications due to their added value in drug delivery precision and targeting.

This Special Issue constitutes the continuation of “Cyclodextrins and Their Derivatives: A Basis for New Drug Formulations—Volume I” and delves into the applications of cyclodextrins and their derivatives for the design and development of innovative drug formulations. This volume will focus on the different stages of cyclodextrin-based formulation development, spanning from initial conceptualization to their clinical applications. Special attention will be given to the drug–cyclodextrin interactions during pre-formulation studies as well as in the formulation process. Additionally, different routes of administration will be elucidated, emphasizing the importance of incorporating cyclodextrins in the formulation. Manuscripts featuring in vivo assessments of cyclodextrin-based formulations are strongly encouraged. This Special Issue places paramount significance on PK/PD studies of cyclodextrins and their derivatives. Both original manuscripts and reviews are welcome!

Prof. Dr. Georgia N. Valsami
Dr. Natassa Pippa
Guest Editors

Dr. Paraskevi Papakyriakopoulou
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cyclodextrins
• cyclodextrin-drug interactions
• formulations
• drug loading
• release kinetics
• routes of administration
• in vitro-in vivo evaluation
• PK/PD studies

• Cyclodextrins and Their Derivatives: A Basis for New Drug Formulations in Molecules (9 articles)